Daphne Continu 2 mg - 0,035 mg tabl.

Country: Belgium

Language: English

Source: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Buy It Now

Active ingredient:

Cyproterone acetate 2 mg (yellow tablet); Ethinylestradiol 35 µg (yellow tablet); Placebo (white tablet)

Available from:

Ceres Pharma SA-NV

ATC code:

G03HB01

INN (International Name):

Cyproterone acetate; Ethinylestradiol; Placebo

Dosage:

2 mg - 0,035 mg

Pharmaceutical form:

Tablet

Composition:

Cyproterone acetate 2 mg; Ethinylestradiol 35 µg; Placebo

Administration route:

Oral use

Therapeutic area:

Cyproterone and Estrogen

Product summary:

CTI code: 459191-03 - Pack size: 6 x 28 (21 + 7) - Commercialisation status: NO - FMD code: 05430000476157 - CNK code: 3189677 - Delivery mode: Medical prescription; CTI code: 459191-02 - Pack size: 3 x 28 (21 + 7) - Commercialisation status: NO - FMD code: 05430000476140 - CNK code: 3189701 - Delivery mode: Medical prescription; CTI code: 459191-01 - Pack size: 28 (21 + 7) - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 459191-04 - Pack size: 13 x 28 (21 + 7) - Commercialisation status: NO - FMD code: 05430000476164 - CNK code: 3189685 - Delivery mode: Medical prescription

Authorization status:

Commercialised: No

Authorization date:

2014-06-03

Documents in other languages

Patient Information leaflet Patient Information leaflet German 01-07-2022
MMR MMR German 12-07-2022
Patient Information leaflet Patient Information leaflet French 01-07-2022
Patient Information leaflet Patient Information leaflet Dutch 01-07-2022